Crossmark

Heart Valve Disease Awareness Survey 2017: what did we achieve since 2015?

Crossref DOI link: https://doi.org/10.1007/s00392-018-1312-5

Published Online: 2018-06-25

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gaede, Luise

Aarberge, Lars

Brandon Bravo Bruinsma, George

Macarthy, Philip

Musumeci, Francesco

Zamorano, Pepe

Möllmann, Helge
License Information

Text and Data Mining valid from 2018-06-25
More Information

Article History

Received: 2 May 2018

Accepted: 20 June 2018

First Online: 25 June 2018

Change Date: 28 August 2018

Change Type: Correction

Change Details: The first and last names of all authors were interchanged in the original publication.

Compliance with ethical standards

:

: L. Gaede is a consultant for Abbott vascular and Edwards Lifesciences. H. Möllmann has received speaker’s honoraria from Edwards Lifesciences, and proctor and speaker’s honoraria from Abbott and Medtronic. G. J. Brandon Bravo Bruinsma is a consultant for Edwards Lifesciences and CEC member for LivaNova. J. Zamorano has received research grants from Edwards Lifesciences. L. Aarberge has been a proctor for Edwards Lifesciences. The other authors have no conflicts of interest to declare.